Glutamic acid decarboxylase and islet cell antibodies in IDDM and first-degree relatives in Andalusian

被引：0
|
作者：
Ortego, J
Guerrero, F
Rodriguez, C
Aguilar, M
Gavilan, I
Escobar, L
Palomo, MJ
Freire, JM
Carrasco, M
Brieva, JA
机构：
[1] H PUERTA DEL MAR,ENDOCRINOL UNIT,CADIZ,SPAIN
[2] H PUERTA DEL MAR,IMMUNOL UNIT,CADIZ,SPAIN
来源：
DIABETOLOGIA | 1997年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [1] DO GLUTAMIC-ACID DECARBOXYLASE ANTIBODIES IMPROVE THE PREDICTION OF IDDM-I IN FIRST-DEGREE RELATIVES AT RISK FOR IDDM
    SCHMIDLI, RS
    COLMAN, PG
    HARRISON, LC
    [J]. JOURNAL OF AUTOIMMUNITY, 1994, 7 (06) : 873 - 879
  • [2] Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM
    Seissler, J
    Morgenthaler, NG
    Achenbach, P
    Lampeter, EF
    Glawe, D
    Payton, M
    Christie, M
    Scherbaum, WA
    [J]. DIABETOLOGIA, 1996, 39 (11) : 1351 - 1356
  • [3] Islet cell antibodies associate with the presence of enteroviral RNA while glutamic acid decarboxylase antibodies do with insulin resistance in first degree relatives of type 1 diabetes
    Cabrera-Rode, E.
    Sarmiento, L.
    Cuba, I.
    Molina, G.
    Fonseca, M.
    Heng-Hung, L.
    Arranz, C.
    Dominguez, E.
    Gonzalez, P.
    Diaz-Horta, O.
    [J]. DIABETOLOGIA, 2008, 51 : S145 - S145
  • [4] High prevalence of thyroid-antibodies in first-degree relatives of IDDM patiens with islet-autoantibody positivity.
    Hatziagelaki, E
    Jaeger, C
    Petzoldt, R
    Seissler, J
    Scherbaum, WA
    [J]. DIABETOLOGIA, 1999, 42 : A97 - A97
  • [5] Clinical evaluation of autoantibodies to glutamic acid decarboxylase and islet cell in the diagnosis of IDDM
    Xiu, LL
    Yu, BJ
    Liang, YQ
    Chen, H
    Zheng, LY
    Yao, B
    Xiao, HP
    Xu, SZ
    [J]. ADVANCES OF DIABETES MELLITUS IN EAST ASIA, 1997, 1141 : 99 - 100
  • [6] Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression
    Jaeger, C
    Hering, BJ
    Hatziagelaki, E
    Federlin, K
    Bretzel, RG
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (01): : 45 - 48
  • [7] Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression
    C. Jaeger
    B. J. Hering
    E. Hatziagelaki
    K. Federlin
    R. G. Bretzel
    [J]. Journal of Molecular Medicine, 1999, 77 : 45 - 48
  • [8] LONG-TERM RISK OF IDDM IN FIRST-DEGREE RELATIVES OF PATIENTS WITH IDDM
    LORENZEN, T
    POCIOT, F
    HOUGAARD, P
    NERUP, J
    [J]. DIABETOLOGIA, 1994, 37 (03) : 321 - 327
  • [9] Islet cell and glutamic acid decarboxylase antibodies in fibrocalculous pancreatic diabetes
    Mohan, V
    Deepa, R
    Bhatia, E
    Hitman, G
    Mackay, IR
    Zimmet, PZ
    [J]. DIABETOLOGIA, 1997, 40 : 290 - 290
  • [10] Glutamic acid decarboxylase and islet cell antibodies in healthy Estonian children
    Adojaan, B
    Sabbah, E
    Vähäsalo, P
    Åkerblom, HK
    Podar, T
    Knip, M
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1999, 12 (05): : 667 - 672
12345